Video

Evolution of Personalized Medicine and Positive Outcomes

Personalized medicine has changed considerably following rapid developments in the technology, both in terms of things that can be addressed by genetic and genomic information, as well as sophisticated methods that have been devised to be able to use this information, according to Edmund Pezalla, MD, MPH.

Particularly in oncology, Pezalla thinks drug development has been the primary driver for the use of personalized medicine—drugs that are targeted for specific markers expressed on particular tumor types. “That has been extremely helpful in getting patients the right therapies. The sophistication has vastly improved and that has definitely helped.”

The early phase of personalized medicine, he explained, was used to test drug metabolism and other things that did not yield improved patient outcomes or lead to better treatment decisions. Pezalla believes this scenario has now changed, both in oncology and other therapeutic areas such as, rheumatoid arthritis.


Related Videos
Screenshot of an interview with Evangelia Vlachou, MD
Screenshot of an interview with Barry Goy, MD
1 expert is featured in this series.
5 experts are featured in this series
5 experts are featured in this series.
5 experts are featured in this series.
Dr Michael Bernstein
Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine
Debra Patt, MD, PhD, MBA, MPH
2 experts in this video
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo